Stefan Vöö

Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis

Rémy L.M. Mostard, Stefan Vöö, Marinus J.P.G. van Kroonenburgh et al. · Respiratory Medicine · 2011 · 189 citations · Full text

Inflammation, Autoimmune Disease, Immunology +5

Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score

Frederik A. Verburg, David G. Pfister, Axel Heidenreich et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 179 citations

Psa Levels, Urology, Genitourinary Cancer +6

Severity of pulmonary involvement and 18F-FDG PET activity in sarcoidosis

Rémy L.M. Mostard, Johny Verschakelen, Marinus J.P.G. van Kroonenburgh et al. · Respiratory Medicine · 2012 · 113 citations · Full text

Advanced Lung Disease, Pathology, 18F-fdg Pet Activity +4

Quantitative SPECT: the time is now

John Dickson, James C Ross, Stefan Vöö · EJNMMI Physics · 2019 · 84 citations · Full text

Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents

Pierre Mineur, Alain Colige, Christophe Deroanne et al. · The Journal of Cell Biology · 2007 · 81 citations · Full text

Splice Variant, Vegf111 Expression, Cell Proliferation +18